Catalog #: K1106 (1106)
For in vitro diagnostic use.
Biopool Chromolize PAI-1 is a bio immunoassay (BIA) for the quantitative
determination of active human plasminogen activator inhibitor, type 1 (PAI-
1) in human plasma.
An increased plasma level of PAI-1is an important reason for impaired fibrinolytic function and may be associated with thrombotic diseases. Increased levels of PAI-1 have also been found in conditions such as normal pregnancyand sepsis.
Principle
Chromolizeä PAI-1 is an immunoactivity assay. Active tPA is lyophilized while immobilised on the surface of the microtest well. After reconstitution, plasma samples containing PAI-1 are added and active PAI-1 reacts with the bound tPA. Simultaneously, an HRP-conjugated monoclonal antibody (MA 12A4) to PAI-1 is added. After incubation, unbound sample and conjugated antibody are washed away and the bound PAI-1 quantified with an HRP-sensitive substrate. The amount of colour developed is directly proportional to the concentration of active PAI-1 in the sample.
Definition of PAI Unit
One unit of PAI-1 activity is defined as the amount of PAI-1 that inhibits one international unit of human single chain tPA as calibrated against the International Standard for tPA, lot 86/670 distributed by NIBSC, Holly Hill, London, England. The Chromolizeä PAI-1 assay is standardised against the NIBSC PAI-1 standard 92/654.
Reagents -- Composition, Packaging, Storage and Stability
The unreconstituted reagents are stable until the expiration date indicated on the label when stored at 2-8°C
Additional Material Required (but not provided):
Cleared: FDA, Canadian Licensing
| Name | Type | Size |
|---|---|---|
| Biopool Fibrinolysis Flyer | application/pdf | 608.65 kB |
| Chromolize PAI-1 Package Insert | application/pdf | 58.95 kB |
| PAI & tPA Kit Comparison Sheet | application/pdf | 30.55 kB |